Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...

CFO Beth Jantzen reported total revenues of $1.2 million for Q1 2025, a year-over-year increase driven by higher product revenue from DNA Tagging and increased isotopic testing services. Operating ...

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

Concord Biotech Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 22,295.81 Crore) operating in Pharmaceuticals sector. Concord Biotech Ltd. key Products/Revenue ...